RCE 0.97% 52.0¢ recce pharmaceuticals ltd

Ann: R327 Efficacy against WHO Priority Pathogen Acinetobacter B, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 602 Posts.
    lightbulb Created with Sketch. 361
    And bleach would show a 9-log reduction given the exact same experiment!

    We get it. R327 kills every single pathogen in a test tube. They don't need to keep running this experiment over and over again. Eight years of essentially the same experiment.

    They need to show results in a human. Even an infected mouse would be great.

    Yet, the only experiments that used sick humans are unable to recruit. The burns trial was abandoned after recruiting 4 patients in a year and a half. The current DFI trial is headed the same way, having recruited only 5 patients in over a year. If the pixie juice worked, word would spread, and they would be fighting off participants.



 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.